Literature DB >> 8608435

A survey of Japanese physicians' attitudes and practice in caring for terminally ill cancer patients.

Y Uchitomi1, H Okamura, H Minagawa, A Kugaya, M Fukue, A Kagaya, N Oomori, S Yamawaki.   

Abstract

To clarify the psychiatric liaison issues in cancer care, questionnaires were distributed to physicians at 31 teaching hospitals in Japan, including cancer centers and psychiatrists at 197 teaching hospitals. Data from 329 physicians and 156 psychiatrists showed that the majority of the physicians felt troubled by the psychiatric problems of terminally ill patients. However, actual psychiatric referrals were infrequent. An important factor that interferes with appropriate psychiatric referrals for cancer patients is that most physicians do not usually inform patients of a cancer diagnosis. This, it seems that close communication between physicians and psychiatrists is essential in caring for terminally ill cancer patients in the context of Japanese culture, when the psychiatric consultations are offered.

Entities:  

Mesh:

Year:  1995        PMID: 8608435     DOI: 10.1111/j.1440-1819.1995.tb01857.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  3 in total

1.  Chinese and U.S. internists adhere to different ethical standards.

Authors:  M D Feldman; J Zhang; S R Cummings
Journal:  J Gen Intern Med       Date:  1999-08       Impact factor: 5.128

2.  Psychological process from hospitalization to death among uninformed terminal liver cancer patients in Japan.

Authors:  Yuko Maeda; Akihito Hagihara; Eiko Kobori; Takeo Nakayama
Journal:  BMC Palliat Care       Date:  2006-09-04       Impact factor: 3.234

3.  Measuring motivation for medical treatment: confirming the factor structure of the Achievement Motivation Index for Medical Treatment (AMI-MeT).

Authors:  Taichi Hatta; Keiichi Narita; Keiichi Naria; Kazuhiro Yanagihara; Hiroshi Ishiguro; Toshinori Murayama; Masayuki Yokode
Journal:  BMC Med Inform Decis Mak       Date:  2016-02-19       Impact factor: 2.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.